Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells

Molecular and Cellular Biology

Volumn 17, Issue 6, 1997, Pages 3013-3020

  Chiba, Hideki ^a   Clifford, John ^a   Metzger, Daniel ^a   Chambon, Pierre ^a  

^a PSL Research University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; RETINOID X RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIMERIZATION; EMBRYONAL CARCINOMA; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0030947316     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.6.3013     Document Type: Article

References (45)

1. Atencia, R., M. Garcia-Sanz, F. Unda, and J. Arechaga. 1994. Apoptosis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp. Cell Res. 214:663-667.
2. Bouillet, P., M. Oulad-Abdelghani, S. Vicaire, J.-M. Garnier, B. Schuhbaur, P. Dollé, and P. Chambon. 1995. Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2). Dev. Biol. 170:420-433.
3. Boylan, J., D. Lohnes, R. Taneja, P. Chambon, and L. J. Gudas. 1993. Loss of retinoic acid receptor γ function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc. Natl. Acad. Sci. USA 90:9601-9605.
4. Boylan, J., T. Lufkin, C. C. Achkar, R. Taneja, P. Chambon, and L. J. Gudas. 1995. Targeted disruption of retinoic acid receptor α (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol. 15:843-851.
5. Chambon, P. 1994. The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol: 5:115-125.
6. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB. J. 10:1187-1197.
7. Chen, J. Y., S. Penco, J. Ostrowski, P. Balaguer, M. Pons, J. E. Starrett, P. Reczek, P. Chambon, and H. Gronemeyer. 1995. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14:1187-1197.
8. Chiba, H., J. Clifford, D. Metzger, and P. Chambon. Specific and redundant functions of RXR/RAR heterodimers in differentiation, proliferation and apoptosis of F9 embryonal carcinoma cells. Submitted for publication.
9. Clifford, J., H. Chiba, D. Sobieszczuk, D. Metzger, and P. Chambon. 1996. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J. 15:4142-4155.
10. De Simone, V., L. D. Magistris, D. Lazzaro, J. Gerstner, P. Monaci, A. Nicosia, and R. Cortese. 1991. LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J. 10:1435-1443.
11. Durand, B., M. Saunders, P. Leroy, M. Leid, and P. Chambon. 1992. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell 71:73-85.
12. Gaub, M.-P., C. Rochette-Egly, Y. Lutz, S. Ali, H. Matthes, I. Scheuer, and P. Chambon. 1992. Immunodetection of multiple species of retinoic acid receptor a: evidence for phosphorylation. Exp. Cell Res. 201:335-346.
13. Giguère, V. 1994. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev. 15:61-79.
14. Glass, C. K. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:391-407.
15. Gronemeyer, H., and V. Laudet. 1995. Nuclear receptors. Protein Profile 2:1173-1308.
16. Gudas, L. J., M. B. Sporn, and A. B. Roberts. 1994. Cellular biology and biochemistry of the retinoids, p. 443-520. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.), The retinoids: biology, chemistry, and medicine. Raven Press, New York, N.Y.
17. Hogan, B. L. M., D. Barlow, and R. Tilly. 1983. F9 teratocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse embryo. Cancer Surv. 2:115-140.
18. Kastner, P., M. Leid, and P. Chambod. 1994. The role of nuclear retinoic acid receptors in the regulation of gene expression, p. 189-238. In R. Blomhoff (ed.), Vitamin A in health and disease. Marcel Dekker, Inc., New York, N.Y.
19. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
20. Kastner, P., M. Mark, N. Ghyselinck, W. Krezel, V. Dupé, J. M. Grondona, and P. Chambon. 1997. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124:313-326.
21. Keaveney, M., and H. G. Stunnenberg. 1995. Retinoic acid receptors, p. 187-242. In P. A. Baeuerle (ed.), Inducible gene expression, vol. 2. Birkhäuser, Boston, Mass.
22. La Vista-Picard, N., P. Hobbs, M. Phahl, M. I. Dawson, and M. Pfahl. 1996. The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal. Mol. Cell. Biol. 16:4137-4146.
23. Lehmann, J. M., L. Jong, A. Fanjul, J. F. Cameron, X. P. Lu, P. Haefner, M. I. Dawson, and M. Pfahl. 1992. Retinoids selective for retinoid X receptor response pathways. Science 258:1944-1946.
24. Leid, M., P. Kastner, and P. Chambon. 1992. Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochcm. Sci. 17:427-433.
25. Leid, M., P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, J-Y. Chen, A. Staub, J.-M. Garnier, S. Mader, and P. Chambon. 1992. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395.
26. Lufkin, T., D. Lohnes, M. Mark, A. Dierich, P. Gorry, M.-P. Gaub, M. LeMeur, and P. Chambon. 1993. High postnatal lethality and testis degeneration in retinoic acid receptor α mutant mice. Proc. Natl. Acad. Sci. USA 90:7225-7229.
27. Mangelsdorf, D. J., K. Umesono, and R. M. Evans. 1994. The retinoid receptors, p. 319-349. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.), The retinoids: biology, chemistry and medicine. Raven Press, New York, N.Y.
28. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
29. Marshall, H., M. Studer, H. Pöpperl, S. Aparicio, A. Kuroiwa, S. Brenner, and R. Krumlauf. 1994. A conserved retinoic acid response element required for early expression of the homeobox gene Hoxb-1. Nature 370:567-571.
30. Martin, C. A., L. M. Ziegler, and J. L. Napoli. 1990. Retinoic acid, dibutyryl-cAMP, and differentiation affect the expression of retinoic acid receptors in F9 cells. Proc. Natl. Acad. Sci. USA 87:4804-4808.
31. Murphy, P., and R. E. Hill. 1991. Expression of the mouse labial-like homeobox-containing genes, Hox 2.9 and Hox 1.6, during segmentation of the hindbrain. Development 111:61-74.
32. Nagpal, S., M. Saunders, P. Kastner, B. Durand, H. Nakshatri, and P. Chambon. 1992. Promoter context-and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70:1007-1019.
33. Pöpperl, H., M. Blenz, M. Studer, S.-K. Chan, S. Aparicio, S. Brenner, R. S. Mann, and R. Krumlauf. 1995. Segmental expression of Hoxb-1 is controlled by a highly conserved autoregulatory loop dependent upon exd/pbx. Cell 81:1031-1042.
34. Rochette-Egly, C., Y. Lutz, M. Saunders, I. Scheuer, M.-P. Gaub, and P. Chambon. 1991. Retinoic acid receptor γ: specific immunodetection and phosphorylation. J. Cell Biol. 115:535-545.
35. Rochette-Egly, C., M.-P. Gaub, Y. Lutz, S. Ali, I. Scheuer, and P. Chambon. 1992. Retinoic acid receptor β: immunodetection and phosphorylation on tyrosine residues. Mol. Endocrinol. 6:2197-2209.
36. Rochette-Egly, C., Y. Lutz, V. Pfister, S. Heyberger, I. Scheuer, P. Chambon, and M.-P. Gaub. 1994. Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. Biochem. Biophys. Res. Commun. 204:525-536.
37. Roy, B., R. Taneja, and P. Chambon. 1995. Synergistic activation of expression of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol. 15:6481-6487.
38. Sleigh, M. J. 1992. Differentiation and proliferation in mouse embryonal carcinoma cells. BioEssays 14:769-775.
39. Smith, W. C., H. Nakshatri, P. Leroy, J. Ress, and P. Chambon. 1991. A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. EMBO J. 10:2223-2230.
40. Strickland, S. 1981. Mouse teratocarcinoma cells: prospects for the study of embryogenesis and neoplasia. Cell 24:277-278.
41. Studer, M., H. Pöpperl, H. Marshall, A. Kuroiwa, and R. Krumlauf. 1994. Role of conserved retinoic acid response element in rhombomere restriction of Hoxb-1. Science 265:1728-1732.
42. Taneja, R., P. Bouillet, J. F. Boylan, M.-P. Gaub, B. Roy, L. J. Gudas, and P. Chambon. 1995. Reexpression of retinoic acid receptor (RAR)γ or overexpression of RARα or RARβ in RARγ-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Natl. Acad. Sci. USA 92:7854-7858.
43. Taneja, R., B. Roy, J.-L. Plassat, C. F. Zusi, J. Ostrowski, P. R. Reczek, and P. Chambon. 1996. Cell-type and promoter-context dependent RAR redundancies for RARβ2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Natl. Acad. Sci. USA 93: 6197-6202.
44. Wan, Y.-J., L. Wang, and T.-C. Wu. 1994. The expression of retinoid X receptor genes is regulated by all-trans-and 9-cis-retinoic acid in F9 teratocarcinoma cells. Exp. Cell Res. 210:56-61.
45. Zelent, A., A. Krust, M. Petkovich, P. Kastner, and P. Chambon. 1989. Cloning of murine α and β retiroic acid receptors and a novel receptor γ predominantly expressed in skin. Nature 339:714-717.